SARS CoV-2 Mutations Provide Clues on Origins, Spread
GEN Article: Supercharge Antibody Discovery Workflows with High-Throughput SPR
PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization
Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairman of the Board of Directors
Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-free Assay
GEN Article: Eliminating Bottlenecks in mAb Drug Discovery
Twist Biopharma screens massive antibody libraries with the Carterra LSA to discover therapeutic antibodies in just weeks.
Podcast: Tim Germann our Chief Commercial Officer Discusses how Carterra has Become an Innovator and Driving Force in Therapeutic Antibody Discovery
Nature Article: Speeding Antibody Screening for Drug Development
Advanced screening technology can dramatically accelerate the hunt for effective treatments for cancer, COVID-19 and more.